share_log

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

HeartCore Expands Partnership With Heart-Tech Health To Implement AI Capabilities Into Its Med-Tech Platform.

HeartCore扩大了与Heart-Tech Health的合作伙伴关系,将人工智能功能引入其医疗技术平台。
Benzinga ·  04/22 08:44

HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division ("AI Division") has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech platform.

总部位于东京的领先企业软件和咨询服务公司HeartCore Enterprises, Inc.(纳斯达克股票代码:HTCR)(“HeartCore” 或 “公司”)宣布,其人工智能(AI)软件开发部(“人工智能部门”)已与Heart-Tech Health合作,在其医疗技术平台中实施人工智能功能。

Heart-Tech Health offers a suite of SaaS solutions designed to identify women's cardiovascular risks at an early stage. Its proprietary software, Adesso, offers a comprehensive risk assessment and personalized health and wellness programs aimed to enhancing healthcare accessibility for all women. Expanding upon the previous engagement with the Company's subsidiary, Sigmaways, HeartCore's AI Division will now develop the AI data base for specific applications and insights, in addition to implementing natural language learning applications to enhance user experience within the Adesso Heart Score platform.

Heart-Tech Health提供了一套SaaS解决方案,旨在尽早识别女性的心血管风险。其专有软件Adesso提供全面的风险评估和个性化的健康和保健计划,旨在提高所有女性获得医疗保健的机会。在先前与公司子公司Sigmaways的合作基础上,HeartCore的人工智能部门现在将为特定应用和见解开发人工智能数据库,此外还将实施自然语言学习应用程序以增强Adesso Heart Score平台内的用户体验。

"Scaling up our partnership with HeartCore is a crucial step in technologically advancing our Adesso platform," said Heart-Tech Health Founder and CEO Dr. Suzanne Steinbaum. "At the heart of Adesso lies a commitment to educating and empowering women about cardiovascular risks early on to combat this epidemic. Our software's workflow has undergone substantial improvement, coupled with invaluable leadership guidance since engaging with Sigmaways and their talented development team last year. By partnering with HeartCore's AI division, we aim to harness the potential capabilities of artificial intelligence to propel our platform's efficiency, reach, and accessibility to continue making impactful strides in women's cardiovascular health awareness and prevention."

Heart-Tech Health创始人兼首席执行官苏珊娜·斯坦鲍姆博士表示:“扩大与HeartCore的合作伙伴关系是推进Adesso平台技术发展的关键一步。”“Adesso的核心是致力于尽早对女性进行心血管风险的教育和赋权,以对抗这种流行病。自去年与Sigmaways及其才华横溢的开发团队合作以来,我们的软件工作流程得到了实质性的改进,并得到了宝贵的领导指导。通过与HeartCore的人工智能部门合作,我们的目标是利用人工智能的潜在能力来推动我们平台的效率、覆盖范围和可访问性,继续在女性心血管健康意识和预防方面取得有影响力的进步。”

HeartCore CEO Sumitaka Kanno Yamamoto added: "I am pleased to announce our second contract awarded to our newly established AI division. AI innovation pairs seamlessly into our broader suite of software solutions, and this contract serves as a prime example of the cross-selling opportunities with our clients across our software business. Our dedicated team continues to make headway, securing new opportunities in the U.S. markets as we actively execute our global expansion initiatives. We are committed to leveraging the full potential and capabilities of AI to propel companies like Heart-Tech Health to drive business success and foster positive societal impact."

HeartCore首席执行官菅野纯隆补充说:“我很高兴地宣布,我们向新成立的人工智能部门授予了第二份合同。人工智能创新与我们更广泛的软件解决方案套件无缝结合,该合同是我们在软件业务中与客户交叉销售机会的典型例子。我们的专业团队继续取得进展,在我们积极执行全球扩张计划的同时,确保了美国市场的新机遇。我们致力于充分利用人工智能的潜力和能力,推动像Heart-Tech Health这样的公司推动业务成功并产生积极的社会影响。”

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发